Document is current
Any future updates will be listed below
-
Authors
Lombardi, Enrico https://orcid.org/0000-0003-4749-9091
Gambazza, Simone
Pradal, Ugo
Braggion, Cesare
-
Funding
Funding for this research was provided by:
Vertex Pharmaceuticals (Italy) Srl (Please see text of the manuscript)
- License Information
-
More Information
Article History
Received: 19 October 2018
Accepted: 16 April 2019
First Online: 2 May 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: EL has received fees or travel grants during the past 5 years from Angelini, Boehringer, Chiesi, GSK, Lusofarmaco, Novartis, Omron, Vertex Pharmaceuticals and Vifor; SG reports personal fees from Vertex Pharmaceuticals; CB and UP declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
